Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Visani

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
Haematologica|May 1, 1988
Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycinG Visani, V Rizzoli, A Dinota, et al.
Haematologica|November 1, 1988
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignanciesS Tura, P Mazza, F Gherlinzoni, et al.
Blood|January 1, 1994
In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell lineG Zauli, M Vitale, M C Re, et al.
Leukemia|January 1, 1994
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative GroupH H Gerhartz, R Marcus, A Delmer, et al.
Blut|May 1, 1990
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gammaG Visani, R M Lemoli, P Tosi, et al.
Leukemia & Lymphoma|July 27, 2016
Comparison of the DNA Content, Bromodeoxyuridine Incorporation and Ki-67 Antigen Expression in Human Acute Myeloid LeukemiaP L Tazzari, A Bontadini, M Gobbi, et al.
Haematologica|September 1, 1994
Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT)G Martinelli, R M Lemoli, P Farabegoli, et al.
British Journal of Haematology|February 1, 1994
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case reportG Visani, P Tosi, P L Zinzani, et al.
The New England Journal of Medicine|January 26, 1995
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative GroupsR A Zittoun, F Mandelli, R Willemze, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomasS Tura, P Mazza, F Gherlinzoni, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
Haematologica|May 1, 1988
Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycinG Visani, V Rizzoli, A Dinota, et al.
Haematologica|November 1, 1988
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignanciesS Tura, P Mazza, F Gherlinzoni, et al.
Blood|January 1, 1994
In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell lineG Zauli, M Vitale, M C Re, et al.
Leukemia|January 1, 1994
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative GroupH H Gerhartz, R Marcus, A Delmer, et al.
Blut|May 1, 1990
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gammaG Visani, R M Lemoli, P Tosi, et al.
Leukemia & Lymphoma|July 27, 2016
Comparison of the DNA Content, Bromodeoxyuridine Incorporation and Ki-67 Antigen Expression in Human Acute Myeloid LeukemiaP L Tazzari, A Bontadini, M Gobbi, et al.
Haematologica|September 1, 1994
Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT)G Martinelli, R M Lemoli, P Farabegoli, et al.
British Journal of Haematology|February 1, 1994
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case reportG Visani, P Tosi, P L Zinzani, et al.
The New England Journal of Medicine|January 26, 1995
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative GroupsR A Zittoun, F Mandelli, R Willemze, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomasS Tura, P Mazza, F Gherlinzoni, et al.
Pageof 22